1-165728104-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_019026.6(TMCO1):c.486C>T(p.Leu162=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0354 in 1,607,392 control chromosomes in the GnomAD database, including 1,221 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.029 ( 107 hom., cov: 32)
Exomes 𝑓: 0.036 ( 1114 hom. )
Consequence
TMCO1
NM_019026.6 synonymous
NM_019026.6 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.980
Genes affected
TMCO1 (HGNC:18188): (transmembrane and coiled-coil domains 1) This locus encodes a transmembrane protein. Mutations at this locus have been associated with craniofacial dysmorphism, skeletal anomalies, and cognitive disability. Mutations at this locus have also been associated with open angle glaucoma blindness. Alternatively spliced transcript variants have been described. [provided by RefSeq, Jan 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.76).
BP6
Variant 1-165728104-G-A is Benign according to our data. Variant chr1-165728104-G-A is described in ClinVar as [Benign]. Clinvar id is 1235043.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.98 with no splicing effect.
BA1
GnomAdExome4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.0667 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TMCO1 | NM_019026.6 | c.486C>T | p.Leu162= | synonymous_variant | 7/7 | ENST00000367881.11 | |
TMCO1 | NM_001256164.1 | c.537C>T | p.Leu179= | synonymous_variant | 7/7 | ||
TMCO1 | NM_001256165.1 | c.450C>T | p.Leu150= | synonymous_variant | 7/7 | ||
TMCO1 | NR_045818.1 | n.580C>T | non_coding_transcript_exon_variant | 7/7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TMCO1 | ENST00000367881.11 | c.486C>T | p.Leu162= | synonymous_variant | 7/7 | 1 | NM_019026.6 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0290 AC: 4412AN: 152134Hom.: 107 Cov.: 32
GnomAD3 genomes
AF:
AC:
4412
AN:
152134
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0338 AC: 8489AN: 250914Hom.: 208 AF XY: 0.0331 AC XY: 4489AN XY: 135684
GnomAD3 exomes
AF:
AC:
8489
AN:
250914
Hom.:
AF XY:
AC XY:
4489
AN XY:
135684
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0361 AC: 52521AN: 1455140Hom.: 1114 Cov.: 31 AF XY: 0.0357 AC XY: 25852AN XY: 723894
GnomAD4 exome
AF:
AC:
52521
AN:
1455140
Hom.:
Cov.:
31
AF XY:
AC XY:
25852
AN XY:
723894
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0290 AC: 4421AN: 152252Hom.: 107 Cov.: 32 AF XY: 0.0280 AC XY: 2087AN XY: 74430
GnomAD4 genome
AF:
AC:
4421
AN:
152252
Hom.:
Cov.:
32
AF XY:
AC XY:
2087
AN XY:
74430
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
31
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 28, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 15, 2018 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Craniofacial dysmorphism, skeletal anomalies, and impaired intellectual development 1 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Sep 10, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at